These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21638071)

  • 1. Are tangles as toxic as they look?
    Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT
    J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sources of extracellular tau and its signaling.
    Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
    J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimalistic in vitro systems for investigating tau pathology.
    Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
    J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau as a therapeutic target for Alzheimer's disease.
    Boutajangout A; Sigurdsson EM; Krishnamurthy PK
    Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Alzheimer-type lesions in cognitively normal subjects.
    Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
    Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.
    Brunden KR; Ballatore C; Crowe A; Smith AB; Lee VM; Trojanowski JQ
    Exp Neurol; 2010 Jun; 223(2):304-10. PubMed ID: 19744482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.
    Detrez JR; Maurin H; Van Kolen K; Willems R; Colombelli J; Lechat B; Roucourt B; Van Leuven F; Baatout S; Larsen P; Nuydens R; Timmermans JP; De Vos WH
    Neurobiol Dis; 2019 Jul; 127():398-409. PubMed ID: 30878534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic tau aggregation in AD.
    Takashima A
    Adv Exp Med Biol; 2015; 822():3-9. PubMed ID: 25416970
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer's pathology.
    Zwang TJ; Sastre ED; Wolf N; Ruiz-Uribe N; Woost B; Hoglund Z; Fan Z; Bailey J; Nfor L; Buée L; Nilsson KPR; Hyman BT; Bennett RE
    Cell Rep; 2024 Aug; 43(8):114574. PubMed ID: 39096489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase activation precedes and leads to tangles.
    de Calignon A; Fox LM; Pitstick R; Carlson GA; Bacskai BJ; Spires-Jones TL; Hyman BT
    Nature; 2010 Apr; 464(7292):1201-4. PubMed ID: 20357768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.